- Chen D, Zhao M, Mundy G R. Bone morphogenic proteins. Growth Factors 2004; 22(4)233–41
- Connor J M. Fibrodysplasia ossificans progressiva - lessons from rare malides. N Engl J Med 1996; 335: 591–3
- Genesis. 19: 1–26, The Bible
- Kaplan F S. Fibrodysplasia ossificans progressiva. An historical perspective. Clin Rev Bone Min Metab 2005; 3(3–4)179–81
- Kaplan F S, Tabas J A, Gannon F H, Finkel G, Hahn G V, Zasloff M A. The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg (Am) 1993; 75: 220–30
- Kaplan F S, Shore E M, Glaser D L, Emerson S. The medical management of fibrodysplsia ossificans progressiva: Current treatment considerations. Clin Proc Intl Clin Consort FOP 2005; 1(3)1–71
- Kaplan F S, Glaser D L, Pignolo R J, Shore E M. A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin Biol Ther 2007; 7(5)705–12
- Kitterman J A, Kantanie S, Rocke D M, Kaplan F S. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 2005; 116: 654–61
- Magryta C J, Kligora C J, Temple T H, Malik R K. Clinical presentation of fibrodysplasia ossificans progressiva: Pitfalls in diagnosis. J Pediatr Hematol Oncol 1999; 21(6)539–43
- Lettres Patin G, Guy Patin choisies de fev. M. Cologne. Piere du Laurens 1692; 1: 28–9
- Shore E M, Xu M, Feldman G J, Fenstermacher D A, Brown M A, Kaplan F S. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nature Genetics 2006; 38(5)525–7
- Smith R. Fibrodysplasia ossificans progressiva: clinical lessons from a rare disease. Clin Orthop 1998, 346: 7–13
Acta Orthopaedica
Volume 79, 2008 - Issue 3